RECRUITING

Social Experiences and Demographic Factors in the Regulation of Immune Cells

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Immune-mediated inflammatory diseases are a health burden for approximately seven percent of the population of Western nations. Preliminary data suggest variations in ethnic identity and/or geography influence discrimination experiences and inflammatory response trends. This study investigates how geography, ethnicity, and laboratory manipulation of discrimination experiences affect immune cell function and genomic regulation. Flow cytometry and immune cell stimulation will test monocytes collected from peripheral blood for functional effects. Next-generation transcriptomics and epigenomics will assess genomic and epigenetic mechanisms. The hypothesis is that geography, self-identified race, and ethnicity, interacting with laboratory discrimination conditions during the virtual ballgame Cyberball™, significantly affect immune cell function through genomic and epigenetic mechanisms, with perceived discrimination as a moderating factor on the immune outcomes. The transdisciplinary nature of the proposed study aims to provide valuable insights into differential susceptibility to immune-mediated inflammatory diseases across diverse populations. Uncovering these insights will better inform population-relevant interventions for immune-mediated inflammatory diseases.

Official Title

Perceived Discrimination, Geography, and Demographic Effects on Immune Cell Function and Regulation

Quick Facts

Study Start:2025-01-31
Study Completion:2029-06-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06519487

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Non-Hispanic Black, Non-Hispanic White, or Hispanic
  2. * At least 18 years of age
  3. * Lives within 25 miles of, works, or attends Morgan State University, The University of Baltimore or Texas Christian University
  1. * Anyone not identifying as either non-Hispanic Black, non-Hispanic White, or Hispanic,
  2. * Under 18 years old
  3. * Does not live within 25 miles of, works, or attends Morgan State University, the University of Baltimore or Texas Christian University

Contacts and Locations

Study Contact

Ingrid Tulloch K tulloch, PhD
CONTACT
4438852276
ingrid.tulloch@morgan.edu
Sarah E Hill, PhD
CONTACT
817-257-6424
s.e.hill@tcu.edu

Study Locations (Sites)

Morgan State University
Baltimore, Maryland, 21251
United States
Texas Christian University
Fort Worth, Texas, 76129
United States

Collaborators and Investigators

Sponsor: Morgan State University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-01-31
Study Completion Date2029-06-30

Study Record Updates

Study Start Date2025-01-31
Study Completion Date2029-06-30

Terms related to this study

Additional Relevant MeSH Terms

  • Perceived Discrimination
  • RNA
  • Inflammatory Response